The COLOSSUS Project
Colorectal cancer is the third most common cancer in Europe. COLOSSUS is an EU-funded H2020 project that aims to provide new and more effective ways to classify patients with a specific type of colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop better treatments for them. Our ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC that is currently not available.
Project Partners
The COLOSSUS Project brings together a multidisciplinary team of 14 different partners from 8 different countries.
Latest News
Congratulations to Coordinator Prof Annette Byrne, RCSI for her recent HRB Investigator-Led Projects Award
Professor Annette Byrne was one of eight RCSI researchers to have been awarded a total of €2.8m in the 2019 Health Research Board (HRB) Investigator-Led Projects funding programme. Congratulations, Annette! The HRB Investigator-Led Projects scheme [...]
Vall d’Hebron recruits the first COLOSSUS translational trial participant in Spain
Pictured (from L to R) Iosune Baraibar, medical oncologist; Mireia Sanchis, Project Manager; Ariadna Garcia, Research Nurse; Javier Ros, Medical Oncologist; Javier Gonzalo, Project Manager* On November 5, 2019, Dr Rodrigo Dienstmann and the colorectal cancer clinical research team under [...]
Digestive Cancers Europe features COLOSSUS in the DICE October 2019 news
Digestive Cancers Europe (DICE, www.digestivecancers.eu) one of our Related Organisations has featured COLOSSUS and our explainer video in their October 2019 news. We have archived the story here.